BioSpace News Archive

Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for Vicineum™ (oportuzumab monatox-qqrs) for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).

Kiromic BioPharma (NASDAQ: KRBP), a pre-clinical stage biotechnology company using its proprietary DIAMOND® artificial intelligence (“A.I.”) platform to improve drug discovery and development with a therapeutic focus on immune-oncology, today announced its quarterly results for the three and six months ended June 30, 2021, and provided an update on its corporate developments.

Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, reported financial results for the second quarter ended June 30, 2021.

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, announced the appointment of Julie Krop, M.D., as Chief Medical Officer.

Alpha Healthcare Acquisition Corp. today announced the nominees who will stand for election/reelection to its Board of Directors during the August 24, 2021, AHAC special shareholder’s meeting to vote on the proposed business combination with Humacyte, Inc.

Jaguar Health, Inc. today reported consolidated second quarter 2021 financial results.

Recursion today reported financial results and business updates for its second quarter ending June 30, 2021.

Trigone Pharma Ltd. today announced the initiation of a Phase 2 study of TRG-100 in patients with interstitial cystitis/ bladder pain syndrome (IC/BPS).

BioCardia ® , Inc. announced today that the Company’s management team will participate in the following upcoming investor conferences: Q3 Investor Summit Virtual Conference from August 17-18, 2021

Spectral Medical Inc. today announced its financial results for the second quarter ended June 30, 2021, and provided a corporate update.